author-photo

Negar Niki Alami

4

Papers

43

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1–6 receiving opioid substitution therapy

2019 International Journal of Drug Policy
Show All
- Source
- Cite
- Save
Citations (21)
Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)

2019
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials

2018 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (5)
Safety and efficacy of Ombitasvir, Paritaprevir/Ritonavir and Dasabuvir with or without ribavirin in chronic hepatitis C patients receiving opioid substitution therapy: a pooled analysis across 12 clinical trials

2017 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (17)